Artificial Intelligence Among US Hematol...

Dr. Chino welcomes Dr. Christopher Manz, a medical oncologist at Dana-Farber Cancer Institute, to discuss new research highlighting care gaps for those receiving care while in prison. Dr. Manz investigates cancer care delivery and payment policy and how they contribute to dispari ... Show More

Dr. Chino welcomes Dr. Timothy Pawlik and patient advocate Joey Tan discuss new research highlighting national data regarding cannabis use in cancer survivors. Dr. Pawlik is the senior author of the manuscript, "Patterns of Cannabis Use Among Cancer Survivors: Insights From the B ... Show More

Dr. Chino welcomes Dr. Jennifer Miller and breast cancer survivor Megan-Claire Chase to discuss Dr. Miller's recent OP article, "Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for U.S. Food and Drug Administration Novel Oncolog ... Show More

What does the cutting edge of radiation oncology look like for treating triple-negative breast cancer? Tune in to hear experts Drs Kevin Kalinsky and Reshma Jagsi discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarti ... Show More

Join Drs Kevin Kalinsky and Jennifer Litton as they discuss hereditary breast cancer, genetic testing, and therapeutic implications. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991258). The topics and discussions ... Show More

<p><span style= "font-size: 12pt; line-height: 107%; font-family: arial, helvetica, sans-serif;"> Drs. John Sweetenham and Lawrence Shulman discuss the challenges that oncologists will be confronting in 2024 and share insights on how to build clinician resilience and optimize the ... Show More

Join experts Drs Kevin Kalinsky and Priyanka Sharma as they discuss their current approach to neoadjuvant therapy in triple negative breast cancer and how the SCARLET trial might change that. Relevant disclosures can be found with the episode show notes on Medscape (https://www.m ... Show More

Dr. Linda Chu is joined by Dr. Matthew Covington and Dr. Regina Rosenthal to discuss the challenges in diagnosing and treating invasive lobular carcinoma (ILC) of the breast. They explore imaging difficulties, unique metastatic patterns, and strategies for improving detection and ... Show More

Join experts Drs Kevin Kalinsky and Aditya Bardia as they discuss utilizing antibody-drug conjugates in clinic. What is currently available? What are the possible side effects? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape (https:/ ... Show More

Join experts Drs Kevin Kalinsky and Heather McArthur as they discuss the latest studies guiding their decisions when treating patients with TNBC in clinic. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991253). The ... Show More

What were the biggest takeaways from ESMO 2023 related to TNBC and IBC? Tune in to hear experts Drs Kevin Kalinsky and Filipa Lynce discuss. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991259). The topics and dis ... Show More

<p><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Hope Rugo and Sara Tolaney discuss the promise of antibody-drug conjugates (ADCs) in the treatment of breast cancer, highlighting key trials that shed light on matching the right ADC to the right p ... Show More

<p>In this episode of PodMD, experienced sub-specialist Gynaecological Oncologist Dr Rhett Morton will be discussing the topic of ovarian cancer, including how a patient would typically present, the treatment options available, the warning signs to look out for, the likelihood of ... Show More